M. Labbozzetta

发表

In Vitro Modulation of P-Glycoprotein Activity by Euphorbia intisy Essential Oil on Acute Myeloid Leukemia Cell Line HL-60R

M. Tutone, M. Sajeva, P. Poma, 2021, Pharmaceuticals.

Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple-negative breast cancer SUM 159 cells.

P. Poma, M. Labbozzetta, M. Notarbartolo, 2015, Oncology letters.

Frequent alteration of the Yin Yang 1/Raf-1 kinase inhibitory protein ratio in hepatocellular carcinoma.

P. Poma, M. Labbozzetta, M. Notarbartolo, 2011, Omics : a journal of integrative biology.

Influence of CYP 3 A 5 and ABCB 1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients

B. Gridelli, T. Bertani, P. Poma, 2022 .

Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients.

C. Polidori, P. Poma, M. Labbozzetta, 2013, World journal of gastroenterology.

Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of beta-catenin and inhibition of beta-catenin-mediated transactivation.

P. Poma, M. Labbozzetta, M. Notarbartolo, 2004, International journal of molecular medicine.

Essential Oil Composition of Alluaudia procera and in Vitro Biological Activity on Two Drug-Resistant Models

R. Alduina, M. Sajeva, P. Poma, 2019, Molecules.

Essential oil of Cyphostemma juttae (Vitaceae): Chemical composition and antitumor mechanism in triple negative breast cancer cells

M. Sajeva, P. Poma, M. Labbozzetta, 2019, PloS one.

The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: analysis of the possible molecular basis.

M. Rizzi, P. Poma, M. Labbozzetta, 2007, International journal of molecular medicine.

Induction of Apoptosis by the Adenosine Derivative IB-MECA in Parental or Multidrug-Resistant HL-60 Leukemia Cells: Possible Relationship to the Effects on Inhibitor of Apoptosis Protein Levels

P. Poma, M. Labbozzetta, M. Notarbartolo, 2005, Chemotherapy.

Novel insights on [1,2]oxazolo[5,4‐e]isoindoles on multidrug resistant acute myeloid leukemia cell line

P. Poma, M. Labbozzetta, M. Notarbartolo, 2022, Drug development research.

Antitumor Mechanism of the Essential Oils from Two Succulent Plants in Multidrug Resistance Leukemia Cell

J. McCubrey, M. Sajeva, P. Poma, 2019, Pharmaceuticals.

Chemical composition, in vitro antitumor and pro-oxidant activities of Glandora rosmarinifolia (Boraginaceae) essential oil

M. Sajeva, P. Poma, M. Labbozzetta, 2018, PloS one.

Antitumor Effect of Glandora rosmarinifolia (Boraginaceae) Essential Oil through Inhibition of the Activity of the Topo II Enzyme in Acute Myeloid Leukemia

M. Sajeva, P. Poma, M. Labbozzetta, 2022, Molecules.

Synthesis, In Vitro and In Silico Analysis of New Oleanolic Acid and Lupeol Derivatives against Leukemia Cell Lines: Involvement of the NF-κB Pathway

M. Tutone, A. Spinella, P. Poma, 2022, International journal of molecular sciences.

Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities.

R. Baruchello, P. Poma, M. Labbozzetta, 2009, Chemico-biological interactions.

Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells.

M. Rizzi, R. Baruchello, P. Poma, 2008, Bioorganic & medicinal chemistry letters.

Chemical and pharmaceutical evaluation of the relationship between triazole linkers and pore size on cyclodextrin–calixarene nanosponges used as carriers for natural drugs

G. Lazzara, P. Poma, M. Labbozzetta, 2016 .

Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia

J. McCubrey, M. Tutone, M. Sajeva, 2022, Pharmaceuticals.

Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View

P. Poma, M. Labbozzetta, M. Notarbartolo, 2020, International journal of molecular sciences.

Cytotoxicity of oleanolic and ursolic acid derivatives toward hepatocellular carcinoma and evaluation of NF-κB involvement.

A. Spinella, P. Poma, M. Labbozzetta, 2019, Bioorganic chemistry.

Rash and multiorgan dysfunction following lamotrigine: could genetic be involved?

P. Poma, M. Labbozzetta, M. Notarbartolo, 2015, International Journal of Clinical Pharmacy.

Synthesis of Curcumin Derivatives and Analysis of Their Antitumor Effects in Triple Negative Breast Cancer (TNBC) Cell Lines

P. Poma, M. Labbozzetta, M. Notarbartolo, 2019, Pharmaceuticals.

Natural Inhibitors of P-glycoprotein in Acute Myeloid Leukemia

P. Poma, M. Labbozzetta, M. Notarbartolo, 2023, International journal of molecular sciences.

NF-κB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers.

P. Poma, M. Labbozzetta, M. Notarbartolo, 2017, Omics : a journal of integrative biology.

Curcumin as a Possible Lead Compound against Hormone‐Independent, Multidrug‐Resistant Breast Cancer

M. Rizzi, R. Baruchello, L. Inguglia, 2009, Annals of the New York Academy of Sciences.

Antitumor effects of the novel NF-kappaB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production.

P. Poma, M. Labbozzetta, M. Notarbartolo, 2006, International journal of oncology.

Expression of WISPs and of Their Novel Alternative Variants in Human Hepatocellular Carcinoma Cells

M. Labbozzetta, M. Notarbartolo, M. Cervello, 2004, Annals of the New York Academy of Sciences.

Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients.

B. Gridelli, T. Bertani, P. Poma, 2011, International journal of molecular medicine.

The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients.

F. Triolo, B. Gridelli, P. Poma, 2009, Annals of transplantation.

Analysis of possible mechanisms accounting for raf-1 kinase inhibitor protein downregulation in hepatocellular carcinoma.

P. Poma, M. Labbozzetta, M. Notarbartolo, 2012, Omics : a journal of integrative biology.

Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma.

P. Poma, M. Labbozzetta, M. Notarbartolo, 2019, Current molecular medicine.

Significance of Autologous Interleukin‐6 Production in the HA22T/VGH Cell Model of Hepatocellular Carcinoma

P. Poma, M. Labbozzetta, M. Notarbartolo, 2006, Annals of the New York Academy of Sciences.

NF-κB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers.

P. Poma, M. Labbozzetta, M. Notarbartolo, 2017, Omics : a journal of integrative biology.

NF-j B Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers

P. Poma, M. Labbozzetta, M. Notarbartolo, 2017 .

Citrus wastewater as a source of value-added products: Quali-quantitative analysis and in vitro screening on breast cancer cell lines.

P. Poma, M. Labbozzetta, M. Notarbartolo, 2024, Archiv der Pharmazie.